Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The genetic background of Parkinson's disease and novel therapeutic targets.

Expert opinion on therapeutic targets - 1 Oct 2022

Salamon András, Zádori Dénes, Szpisjak László, Klivényi Péter, Vécsei László

Abstract excerpt

INTRODUCTION: Parkinson's disease (PD) is the second most common neurodegenerative disease worldwide. The median age of disease onset is around 60 years. From a genetic point of view, PD is basically considered a sporadic, idiopathic disease, however, hereditary components can be detected in 5-10% of patients. Expanding data are available regarding the targeted molecular therapy of the disease. AREAS COVERED: The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Background
Share to Glucosylceramidase
Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Mutation

Share to Neurodegenerative Diseases

Share to Parkinson Disease

Source

Identifiers

PMID: 36524726
DOI: 10.1080/14728222.2022.2153037

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The genetic background of Parkinson's disease and novel therapeutic targets.PMID 36524726Read ↗

Genetic Forms of Parkinson's Disease.Semantic proximity Read ↗

Updates on the Genetics of Parkinson's Disease: Clinical Implications and Future Treatment.Semantic proximity Read ↗

Genetics of Parkinson's Disease: From Causes to Treatment.Semantic proximity Read ↗

Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism.Semantic proximity Read ↗

An update on the monogenic causes of Parkinson's disease: Impact on patient stratification and personalised medicine.Semantic proximity Read ↗

Genetics of Parkinson's disease.Semantic proximity Read ↗

The genetics of Parkinson disease.Semantic proximity Read ↗

Parkinson's disease: from monogenic forms to genetic susceptibility factors.Semantic proximity Read ↗

Genetics of Parkinson disease.Semantic proximity Read ↗

Parkinson disease: insights in clinical, genetic and pathological features of monogenic disease subtypes.Semantic proximity Read ↗

Parkinson Disease from Mendelian Forms to Genetic Susceptibility: New Molecular Insights into the Neurodegeneration Process.Semantic proximity Read ↗

Parkinson's Disease is Predominantly a Genetic Disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.